How Can AI Find Accounts Ready to Buy?
Bigger lists don't find buyers. Signals do. The signals I track for device companies and practices, and how I score and clean the list.
MedTech · Stage 1: Lead Acquisition · AI & Data
How can AI find accounts that are ready to buy?
By watching for buying signals instead of building bigger lists. For device companies, my strongest signals are FDA activity in the last six months plus recent funding. An agent checks for both every week, then the matches are scored and enriched so a person only works the accounts that actually fit your profile.
AI finds ready-to-buy accounts by watching for signals, not by building bigger lists. For device companies, my two strongest signals are recent FDA activity and recent funding. I have an agent check for both every week, then score and enrich the matches, so a person only works the accounts that fit.
Which signals actually mean ready to buy?
For MedTech companies I look for two things together:
- FDA activity in the last six months. A recent filing, whether a PMA or a 510(k), or a recent clearance or approval.
- Recent funding. Who has money right now. Series A to B is my sweet spot, because that's the commercialization stage.
Grants are a signal too. And I filter on size. My ideal client is under $200 million in revenue and under 200 employees, so anything outside that never reaches my desk.
What does the automated version look like?
Every Saturday morning I get a report. I gave an agent specific homework and specific websites to check. It returns a list of about 10 to 15 businesses a week that match my profile. It knows what I don't sell, so it skips whole categories that would only waste my time.
From there the list flows into a database. The system pulls the top five executives at each company, then I enrich them with work emails, mobile numbers and background. I check financing history the same way. A person still decides who to contact and what to say.
Enrichment is not free. I pay about $1,000 a month for one data enrichment platform alone, to fill in phone numbers and emails and give me a background and a fit read on each contact. Budget for the data, not just the AI. A cheap list with no contact data or no fit score just moves the work back onto your reps.
Does this work for practices, not just device companies?
Yes, but the signals change. For one project I pulled every Medicare-reimbursed practice in a set of specialties, about 4,200 national account records. Then I scored each one on buying signals. Three or more signals together made it tier A. Fewer signals dropped it to a lower tier.
Look past the specialty. The useful questions are about behavior:
- Does the practice already sell other cash-pay services? Then it understands the business side.
- Is it hiring a front-office receptionist? That's a practice telling you it needs office support.
- Does it already offer two or three related services? Then it may want to add the next one.
How do I keep the list from getting noisy?
Most of the work is removing white noise, not getting fancy. Say you pull 20,000 physicians in a specialty, but only about 3,000 of them are open to the kind of therapy you sell. Contact the 3,000. If you can remove half of a 20,000 list right away, you're already more accurate.
Then qualify what's left the old way: budget, a decision maker with authority, a defined need, and a time frame. AI gets you to the right names faster. It doesn't replace that check.
On outreach, I write the templates myself and automation sends them. If someone replies and I haven't answered within 10 minutes, AI sends a short reply so the lead doesn't go cold. Speed matters as much as the list.
Where to start
Write your ideal customer profile in one paragraph: size, stage, specialty, and the two or three signals that mean an account is in market. Set up one weekly automated report against public sources. Score what comes back, enrich the top matches, and have a person review them before any outreach goes out.
Where this fits: stage 1 of the revenue funnel, Lead Acquisition. Read what revenue friction is and how it is measured. See how RevRx AI works with MedTech teams.
This article shares general views on commercial strategy. It is not medical, legal, financial or regulatory advice.
Related articles
Product & Regulatory · MedTech · Stage 1: Lead AcquisitionWhy Your Health Records Are Still Scattered Across Apps
Another health chatbot does not solve a fragmented record. Stephen Rouse describes a consumer app built around portability, visible data and user choice.
- Sales & Teams · MedTech + Consumer Health · Stage 1: Lead Acquisition
AI Sales Strategies That Boost Lead Generation
AI is now a core part of competitive sales execution. What the core technologies do, and a five-step plan to generate more qualified leads.
- Patient Growth · MedTech + Consumer Health · Stage 1: Lead Acquisition
Why Low Conversion Rates Persist and How AI Helps
Low conversion rates signal gaps in the digital customer journey. Seven common causes, from site design to follow-up, and how AI helps fix them.
Related episodes
35:01AI & DataOwn Your Health Data: A Portable AI Health Record on Your Phone
Stephen Rouse, Savva
Jun 21, 2026 (opens YouTube in a new tab)
Read the article: Why Your Health Records Are Still Scattered Across Apps
40:17MedTech & InnovationCombination Products: Why a Syringe Isn't Just a Syringe
Paul Landesman
Oct 17, 2026 (opens YouTube in a new tab)
Read the article: Why Combination Products Stall When the Device Comes Last
29:06MedTech & InnovationHow Moon Surgical Built a Surgical Robot in 16 Months
Ian McEachern
Oct 2, 2026 (opens YouTube in a new tab)
Read the article: Why Medical Device Prototypes Get Stuck Before Production
Is this friction slowing your revenue?
Take the MedTech Revenue Scorecard or book a free Discovery Call.
Free 30-minute call: a commercial snapshot of your business (one strength, weakness, opportunity and threat, prepped before we talk) and your top priority fixes.